The EpiRead and EpiWrite platform will be presented for the first time highlighting high-resolution single-cell mapping of the methylome in conjunction with targeted methylation modifications.
It will be interesting to see where companies developing therapeutics based on epigenome editing technology choose to focus their development efforts over the next few years. For Moonwalk Biosciences ...
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Moonwalk Biosciences, a pioneering epigenetic engineering and medicine company, announced it will present data highlighting its EpiRead and ...
The MarketWatch News Department was not involved in the creation of this content. -- The EpiRead and EpiWrite platform will be presented for the first time highlighting high-resolution single-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results